Hua Medicine Investors

28 investors on Angel Roster list Hua Medicine in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Series B and the largest groups are based in the United States, China and Hong Kong.

Investors are matched on the company name in their portfolio, so companies that share the name Hua Medicine can appear together.

Investors listed
28
With verified email
46%
Most common stage
Series B
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 28 Hua Medicine investors

The most complete profiles first. Showing 28 of 28.

  • Bryan RobertsVerified

    Venture Capital, Entrepreneurship Program, Private Equity Firm · United States

    Series BSeries AAdvertisingHealth CareTelecommunicationsWomen Founded

    Portfolio: Nightfall AI, Biolux Research, Cloudflare, Adavium and 82 more

    Verified email available

  • Carol SuhVerified

    Venture Capital, Investor · United States

    Series BHealth CareLife ScienceBiotechnologyHealth Diagnostics

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • David CruikshankVerified

    Venture Capital, Investor · United States

    Series BHealth CareLife ScienceBiotechnologyHardware

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • Ethan BatraskiVerified

    Venture Capital, Entrepreneurship Program, Private Equity Firm · United States

    Series BSeries AAdvertisingHealth CareRemote Work TechTelecommunications

    Portfolio: Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals and 66 more

    Verified email available

  • Harry BarberVerified

    Venture Capital, Investor · United States

    Series BSeries AHealth CareTelecommunicationsWomen FoundedInvestment Management

    Portfolio: Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals and 64 more

    Verified email available

  • Nimish ShahVerified

    Venture Capital, Investor · United States

    Series AHealth CareTelecommunicationsWomen FoundedInvestment Management

    Portfolio: Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals and 64 more

    Verified email available

  • Sean KendallVerified

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    Series BHealth CareEnterprise SoftwareEnergyChemical

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • Todd GrahamVerified

    Venture Capital, Investor · United States

    Series AHealth CareTelecommunicationsCybersecurityWomen Founded

    Portfolio: Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals and 64 more

    Verified email available

  • Alex RosenVerified

    Venture Capital · United States

    Health CareTelecommunicationsWomen FoundedInvestment Management

    Portfolio: Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals and 64 more

    Verified email available

  • Andrew PangVerified

    Venture Capital, Private Equity Firm · Hong Kong

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health, xInnovent Biologics and 34 more

    Verified email available

  • John ZhuVerified

    Venture Capital · China

    Health CareWomen FoundedBiotechnologyHealth Diagnostics

    Portfolio: GKHT Medical Technology, Helian Health, Forerunner Medical, Medeor Therapeutics and 27 more

    Contact details available

  • Mark McDonnellVerified

    Venture Capital · United States

    Health CareLife ScienceBiotechnologyHealth Diagnostics

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • Tom BrennanVerified

    Venture Capital, Private Equity Firm · United States

    Health CareEnterprise SoftwareLife ScienceInformation Technology (IT)

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • kevin ChiangVerified

    Venture Capital, Private Equity Firm, Micro VC · China

    Health CareEvents ServicesLife ScienceBiotechnology

    Portfolio: Abbisko Therapeutics, Antengene Corporation, Sanyou Medical, Hua Medicine and 13 more

    Verified email available

  • Andrew Gottesdiener

    Venture Capital, Investor · United States

    Series AHealth CareTelecommunicationsWomen FoundedInvestment Management

    Portfolio: Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals and 64 more

    Contact details available

  • Corey Ritter

    Venture Capital, Investor · United States

    Series BHealth CareLife ScienceRoboticsManufacturing

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Contact details available

  • Megan Blewett

    Venture Capital, Investor · United States

    SeedPre-SeedHealth CareTelecommunicationsWomen FoundedInvestment Management

    Portfolio: Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals and 64 more

    Contact details available

  • Nilay Thakar

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Contact details available

  • Rebecca Zhu

    Venture Capital, Investor · China

    SeedHealth CareWomen FoundedManufacturingBiotechnology

    Portfolio: GKHT Medical Technology, Helian Health, Forerunner Medical, Medeor Therapeutics and 27 more

    Contact details available

  • Steve Gillis

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 68 more

    Contact details available

  • Barney Han

    Venture Capital, Private Equity Firm

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health, xInnovent Biologics and 34 more

    Contact details available

  • Charles Chon

    Venture Capital, Private Equity Firm · Hong Kong

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health, xInnovent Biologics and 34 more

    Contact details available

  • Mike Tyrrell

    Venture Capital · United States

    Health CareTelecommunicationsWomen FoundedInvestment Management

    Portfolio: Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals and 64 more

    Contact details available

  • Paul Dossa

    Venture Capital · United States

    Health CareTelecommunicationsWomen FoundedInvestment Management

    Portfolio: Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals and 64 more

    Contact details available

  • Reese Yeh

    Venture Capital, Private Equity Firm

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health, xInnovent Biologics and 34 more

    Contact details available

  • Robert Nelsen

    Venture Capital, Investor · United States

    Health CareLife ScienceBiotechnologyHealth Diagnostics

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 78 more

    Contact details available

  • Tinnie Chau, CFA

    Venture Capital, Private Equity Firm

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health, xInnovent Biologics and 34 more

    Contact details available

  • Walter Schindler

    Private Equity Firm · United States

    Health CareWomen FoundedEnergyLife Science

    Portfolio: Earthanol, SNTech, Ice Energy, Water Health International and 5 more

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Hua Medicine investors are on Angel Roster?

Angel Roster lists 28 Hua Medicine investors. 13 of them (46%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (27), Private Equity Firms (13) and Investment Partner Investors (2). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Hua Medicine investors invest in?

Among those that list a stage, the most common are Series B (9), Series A (6) and Seed (2).

Where are Hua Medicine investors based?

Most are based in the United States (19), China (3) and Hong Kong (2).

Which companies have Hua Medicine investors backed?

The most-backed portfolio companies among them are UNITY Biotechnology (21), Encoded Therapeutics (19), RefleXion Medical (15), Cyteir Therapeutics (15) and Shockwave Medical (15).

How do I contact Hua Medicine investors?

Create a free Angel Roster account to search and filter all 28, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.